Milbank LLP advised EQT’s new purpose-driven strategy on the acquisition of Anticimex.
Anticimex is a leading global pest control specialist and employs around 7,400 people serving more than three million customers in 20 markets worldwide. Anticimex will become the first investment of EQT’s new strategy with longer-term investments and impact at its core.
The transaction with an enterprise value of approx. €6 billion is made together with several long-term investors, including Melker Schörling AB, GIC, AMF and Interogo.
The transaction is expected to close in Q4 2021.
The Milbank team was led by Steffen Oppenländer (Corporate/M&A, Munich) and included partners Thomas Kleinheisterkamp (Tax, Munich); Alexander Rinne (Regulatory, Munich); and Joel Harrison (Technology, London) as well as associates Laura Treublein and Markus von Lutterotti (both Corporate/M&A, Munich); Roy Jackson (Corporate/M&A, Los Angeles); Chris Puttock (Technology, London); Javier Ramos (Litigation, Washington); Stephanie Kam (Global Projects, Singapore); Melchior Raiser and Anna Merkl (both Banking & Leveraged Finance, Munich); as well as Nils Bremer (Regulatory, Munich).